Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 06:00 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy
NCT00788307 · Mayo Clinic · PHASE1 · terminated · last registry update 2026-07-22 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “closed early due to poor accrual” | – | Registry record, Mayo Clinic |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against THRA within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-10-27Results posted on the registry: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Leptin + T3 repletion (NCT00073242)
- 2026-08-31Results posted on the registry: Ohio State University, a drug against THRA (NCT05764369)
- 2026-08-06Results posted on the registry: City of Hope Medical Center, a drug against THRA (NCT03776253)
- 2026-07-23Also stopped (terminated): Henry Ford Health System, a drug against THRA (NCT03941366)
- 2026-07-23Also stopped (terminated): Henry Ford Health System, a drug against THRA (NCT05526079)
- 2026-07-09Results posted on the registry: VA Office of Research and Development, a drug against THRA (NCT04784663)
- 2026-06-26Also stopped (terminated): IBSA Institut Biochimique SA, Tirosint®-SOL + Levothyroxine Sodium (NCT05228184)
- 2026-06-26Results posted on the registry: University of North Carolina, Chapel Hill, a drug against THRA (NCT05929482)
- 2026-06-08Also stopped (terminated): University Hospital, Strasbourg, France, Nitrous Oxide inhalation (NCT05167331)
- 2026-05-29Results posted on the registry: IBSA Institut Biochimique SA, Tirosint®-SOL + Levothyroxine Sodium (NCT05228184)
- 2026-05-22Results posted on the registry: ZimVie, a drug against THRA (NCT02161874)
- 2026-05-19Results posted on the registry: University of Bergen, a drug against THRA (NCT02769507)
- 2026-05-13Results posted on the registry: University Hospitals of North Midlands NHS Trust, a drug against THRA (NCT06050720)
- 2026-03-16Results posted on the registry: Gaia AG, a drug against THRA (NCT06601907)
- 2026-03-16Also stopped (terminated): Gaia AG, a drug against THRA (NCT06601907)
- 2026-03-13Also stopped (terminated): Centre Oscar Lambret, a drug against THRA (NCT02439008)
- 2026-02-10Also stopped (withdrawn): University of Minnesota, Instilled T3 (NCT04725110)
- 2026-01-12Phase 3 first posted: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, Levothyroxine + Placebo (NCT07332273)
- 2025-12-24Results posted on the registry: University of Michigan Rogel Cancer Center, a drug against THRA (NCT04530526)
- 2025-12-19Results posted on the registry: University of Texas Southwestern Medical Center, a drug against THRA (NCT04831138)
- 2025-12-19Also stopped (terminated): University of Texas Southwestern Medical Center, a drug against THRA (NCT04831138)
- 2025-12-04Also stopped (terminated): Centre Hospitalier Régional d'Orléans, a drug against THRA (NCT06603701)
- 2025-11-20Phase 3 first posted: West China Hospital, desiccated thyroid extract (DTE)+levothyroxine (L-T4) (NCT07239674)
- 2025-11-04Phase 3 first posted: GRIN Therapeutics, Inc., Radiprodil + Placebo (NCT07224581)
- 2025-11-04Results posted on the registry: Boehringer Ingelheim, BI 1810631 - trial formulation 1 (TF1) + BI 1810631 - new formulation (NF) (NCT05380947)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision